Apriem Advisors Has $476,000 Holdings in MetLife, Inc. (MET)

Apriem Advisors lessened its holdings in shares of MetLife, Inc. (NYSE:MET) by 29.9% in the third quarter, according to its most recent filing with the SEC. The firm owned 9,160 shares of the financial services provider’s stock after selling 3,900 shares during the quarter. Apriem Advisors’ holdings in MetLife were worth $476,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. BlackRock Inc. boosted its position in MetLife by 2.2% during the 2nd quarter. BlackRock Inc. now owns 69,957,359 shares of the financial services provider’s stock worth $3,843,457,000 after acquiring an additional 1,481,489 shares during the period. Vanguard Group Inc. lifted its holdings in shares of MetLife by 2.1% in the second quarter. Vanguard Group Inc. now owns 66,723,143 shares of the financial services provider’s stock valued at $3,665,769,000 after buying an additional 1,358,523 shares during the period. Franklin Resources Inc. lifted its holdings in shares of MetLife by 1.6% in the second quarter. Franklin Resources Inc. now owns 25,704,204 shares of the financial services provider’s stock valued at $1,412,189,000 after buying an additional 414,032 shares during the period. Epoch Investment Partners Inc. lifted its holdings in shares of MetLife by 208.5% in the third quarter. Epoch Investment Partners Inc. now owns 10,291,110 shares of the financial services provider’s stock valued at $534,623,000 after buying an additional 6,954,917 shares during the period. Finally, Diamond Hill Capital Management Inc. lifted its holdings in shares of MetLife by 2.8% in the second quarter. Diamond Hill Capital Management Inc. now owns 7,033,812 shares of the financial services provider’s stock valued at $386,438,000 after buying an additional 194,883 shares during the period. Institutional investors own 76.37% of the company’s stock.

Shares of MetLife, Inc. (MET) traded down $0.04 during midday trading on Thursday, hitting $53.00. The stock had a trading volume of 3,500,300 shares, compared to its average volume of 5,728,484. MetLife, Inc. has a twelve month low of $44.26 and a twelve month high of $55.91. The stock has a market capitalization of $55,813.94, a P/E ratio of 10.20, a price-to-earnings-growth ratio of 1.33 and a beta of 1.49. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 EPS for the quarter, beating the consensus estimate of $0.90 by $0.19. The business had revenue of $16.10 billion during the quarter, compared to the consensus estimate of $15.47 billion. MetLife had a positive return on equity of 8.81% and a negative net margin of 0.75%. MetLife’s revenue was up 1.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.28 earnings per share. research analysts anticipate that MetLife, Inc. will post 4.43 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 13th. Investors of record on Monday, November 6th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 3.02%. The ex-dividend date is Friday, November 3rd. MetLife’s payout ratio is -320.00%.

In related news, insider Christopher G. Townsend sold 55,712 shares of the company’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the transaction, the insider now directly owns 25,181 shares of the company’s stock, valued at $1,367,076.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christopher G. Townsend sold 82,731 shares of the company’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the transaction, the insider now directly owns 49,660 shares in the company, valued at $2,711,436. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by insiders.

Several analysts have recently weighed in on the company. Royal Bank Of Canada restated an “outperform” rating and issued a $60.00 price objective (up previously from $56.00) on shares of MetLife in a report on Friday, November 3rd. Morgan Stanley upped their price objective on MetLife from $55.00 to $56.00 and gave the company an “equal weight” rating in a report on Friday, November 3rd. Argus upped their price objective on MetLife from $55.00 to $60.00 and gave the company a “buy” rating in a report on Monday, November 6th. Zacks Investment Research upgraded MetLife from a “strong sell” rating to a “hold” rating in a report on Monday, October 9th. Finally, ValuEngine lowered MetLife from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 10th. One analyst has rated the stock with a sell rating, ten have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. MetLife currently has an average rating of “Buy” and a consensus target price of $58.40.

ILLEGAL ACTIVITY NOTICE: This report was posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.thelincolnianonline.com/2017/12/07/apriem-advisors-has-476000-holdings-in-metlife-inc-met.html.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply